Reading Time: < 1 minute

ATLANTA–(BUSINESS WIRE)–Holzer & Holzer, LLC is investigating whether certain statements made by
Intersect ENT, Inc. (“Intersect ENT” or the “Company”)(NASDAQ: XENT)
complied with federal securities laws. On May 6, 2019, Intersect ENT
reported a $10.8 million first quarter loss, lowered its 2019 guidance,
and announced that its CEO will step down on June 5. The price of
Intersect ENT’s stock fell following the announcement.

If you purchased shares of Intersect ENT and suffered a loss on that
investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or
Marshall P. Dees, Esq. at mdees@holzerlaw.com,
or by toll-free telephone at (888) 508-6832 to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its
practice to vigorous representation of shareholders and investors in
litigation nationwide, including shareholder class action and derivative
litigation. Since its founding in 2000, Holzer & Holzer attorneys have
played critical roles in recovering hundreds of millions of dollars for
shareholders victimized by fraud and other corporate misconduct. More
information about the firm is available through its website, www.holzerlaw.com
and upon request from the firm. Holzer & Holzer, LLC has paid for the
dissemination of this promotional communication, and Corey D. Holzer is
the attorney responsible for its content.

Contacts

Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com